实现C反应蛋白测量计量溯源的共识总结
目前基于DA-474参考物质和两种通用免疫测定方法原则已使不同终端测量程序结果良好协调,但新候选参考物质和参考测量程序对现有协调结果的影响尚不明确。研讨会共识认为等效性数据须考虑新参考物质在现有校准层级中的影响,且新参考测量程序须与已验证的候选程序或全球可用的终端测量系统比较。
要点
- 当前CRP计量溯源基于DA-474参考物质和两种通用免疫测定方法原则。
- 新参考物质和参考测量程序需评估对现有协调结果的影响。
- 新参考测量程序须与已验证程序或终端测量系统比较结果。
核心结论
- 等效性数据必须包括新参考物质用于现有终端测量系统校准层级时的影响考量。
- 新参考测量程序必须与另一个现有良好验证的候选参考测量程序或全球可用的终端测量系统比较结果。
主要发现
- 当前计量溯源已使不同终端测量程序对临床样本产生良好协调的结果。
- 新候选参考物质和参考测量程序的性能数据尚不明确其对现有协调结果的影响。
- 血清或血浆中临床相关CRP测量对象为相同亚基的五聚体,增加了高阶参考物质和参考测量程序应用的复杂性。
关键数值与推荐
- JCTLM目前列出的二级可交换认证参考物质为ERM DA-474/IFCC(DA-474)“人血清C反应蛋白”。
- JCTLM目前列出两种通用免疫测定方法原则作为CRP测量计量溯源的基础。
临床怎么用
- 医学实验室终端测量程序实施CRP计量溯源时应基于JCTLM列出的参考物质和方法原则。
- 引入新参考物质或参考测量程序前需评估其对现有校准层级和结果协调性的影响。
局限性
- 支持新候选参考物质性能的数据尚不明确其对现有协调结果的影响。
- CRP五聚体结构增加了高阶参考物质和参考测量程序应用的复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Joint Committee for Traceability in Laboratory Medicine (JCTLM) currently lists the secondary commutable certified reference material (CRM) ERM DA-474/IFCC (DA-474) "C-Reactive Protein in Human Serum" and two generic immunoassay-based method principles as the basis for implementing the metrological traceability of C-reactive protein (CRP) measurements by end-user measurement procedures used by medical laboratories. The current metrological traceability has produced well harmonized results for clinical samples among different end-user measurement procedures. New higher-order pure substance and secondary commutable CRMs have been nominated for listing by the JCTLM. However, the data supporting performance of these new candidate CRMs, including use of new mass spectrometry based candidate reference measurement procedures (RMPs), was not clear regarding the influence that introducing these new CRMs would have on the current well harmonized results achieved with the existing metrological traceability to DA-474. The clinically relevant CRP measurand in blood serum or plasma is a pentamer of identical subunits, which adds complexity to the application of higher-order CRMs and RMPs. The JCTLM convened a workshop in December 2022 to review the appropriate implementation of metrological traceability of CRP measurements. The workshop consensus was that the extent-of-equivalence data must include considerations about the impact of a new CRM when used for its intended purpose in the calibration hierarchies of existing end-user measuring systems; and that a new RMP must compare results with another existing well validated candidate RMP or with a globally available end-user measurement system.
引用
- Miller WG, Panteghini M, Wielgosz R, et al. Implementing metrological traceability of C-reactive protein measurements: consensus summary from the Joint Committee for Traceability in Laboratory Medicine Workshop. Clin Chem Lab Med. 2023. PMID: 37253275. doi:10.1515/cclm-2023-0498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。